Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Base de datos
Tipo del documento
Intervalo de año de publicación
1.
Vaccine ; 37(18): 2511-2519, 2019 04 24.
Artículo en Inglés | MEDLINE | ID: mdl-30940486

RESUMEN

INTRODUCTION: Measles elimination depends on the successful deployment of measles containing vaccine. Vaccination programs often depend on a combination of routine and non-routine services, including supplementary immunization activities (SIAs) and vaccination weeks (VWs), that both aim to vaccinate all eligible children regardless of vaccination history or natural infection. Madagascar has used a combination of these activities to improve measles coverage. However, ongoing massive measles outbreak suggests that the country was in a "honeymoon" period and that coverage achieved needs to be re-evaluated. Although healthcare access is expected to vary seasonally in low resources settings, little evidence exists to quantify temporal fluctuations in routine vaccination, and interactions with other immunization activities. METHODS: We used three data sources: national administrative data on measles vaccine delivery from 2013 to 2016, digitized vaccination cards from 49 health centers in 6 health districts, and a survey of health workers. Data were analyzed using linear regressions, analysis of variance, and t-tests. FINDINGS: From 2013 to 2016, the footprint of SIAs and VWs is apparent, with more doses distributed during the relevant timeframes. Routine vaccination decreases in subsequent months, suggesting that additional activities may be interfering with routine services. The majority of missed vaccination opportunities occur during the rainy season. Health facility organization and shortage of vaccine contributed to vaccination gaps. Children born in June were the least likely to be vaccinated on time. DISCUSSION: Evidence that routine vaccination coverage varies over the year and is diminished by other activities suggests that maintaining routine vaccination during SIAs and VWs is a key direction for strengthening immunization programs, ensuring population immunity and avoiding future outbreaks. FUNDING: Wellcome Trust Fund, Burroughs Wellcome Fund, Gates Foundation, National Institutes of Health.


Asunto(s)
Programas de Inmunización , Vacuna Antisarampión/administración & dosificación , Sarampión/prevención & control , Estaciones del Año , Cobertura de Vacunación/estadística & datos numéricos , Preescolar , Brotes de Enfermedades/prevención & control , Femenino , Personal de Salud , Administración de los Servicios de Salud/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Madagascar , Masculino , Encuestas y Cuestionarios , Cobertura de Vacunación/métodos
2.
Med Vet Entomol ; 32(2): 259-262, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29383746

RESUMEN

Culex antennatus (Diptera: Culicidae), Anopheles coustani (Diptera: Culicidae) and Anopheles squamosus/cydippis were found to be infected with Rift Valley fever virus (RVFV) during an epidemic that occurred in 2008 and 2009 in Madagascar. To understand the roles played by Cx. antennatus and An. coustani in virus maintenance and transmission, RVFV vector competence was assessed in each species. Mosquito body parts and saliva of mosquitoes that fed on RVFV-infected blood were tested for RVFV using real-time quantitative polymerase chain reaction (RT-qPCR) assays. Overall, viral RNA was detected in body parts and saliva at 5 days post-infection (d.p.i.) in both species. At 5 d.p.i., infection rates were 12.5% (3/24) and 15.8% (6/38), disseminated infection rates were 100% (3/3) and 100% (6/6), transmission rates were 33.3% (1/3) and 83.3% (5/6), and transmission efficiencies were 4.2% (1/24) and 13.2% (5/38) in Cx. antennatus and An. coustani, respectively. Although RVFV detected in saliva did not propagate on to Vero cells, these results support potential roles for these two mosquito species in the transmission of RVFV.


Asunto(s)
Anopheles/fisiología , Culex/fisiología , Mosquitos Vectores/fisiología , Fiebre del Valle del Rift/transmisión , Virus de la Fiebre del Valle del Rift/fisiología , Animales , Anopheles/virología , Chlorocebus aethiops , Culex/virología , Madagascar , Mosquitos Vectores/virología , Reacción en Cadena en Tiempo Real de la Polimerasa , Células Vero
3.
Artículo en Inglés | MEDLINE | ID: mdl-28750867

RESUMEN

The circulation of West Nile virus (WNV) in horses was investigated in the Southwest Indian ocean. In 2010, blood samples were collected from a total of 303 horses originating from Madagascar, Mauritius, Reunion and the Seychelles and tested for WNV-specific antibodies. An overall seroprevalence of 27.39% was detected in the Indian Ocean with the highest WNV antibody prevalence of 46.22% (95% CI: [37.4-55.2%]) in Madagascar. The age and origin of the horses were found to be associated with the WNV infection risk. This paper presents the first seroprevalence study investigating WN fever in horses in the Southwest Indian Ocean area and indicates a potential risk of infection for humans and animals. In order to gain a better understanding of WN transmission cycles, WNV surveillance needs to be implemented in each of the countries.


Asunto(s)
Enfermedades de los Caballos/epidemiología , Fiebre del Nilo Occidental/veterinaria , Animales , Anticuerpos Antivirales/sangre , Ensayo de Inmunoadsorción Enzimática , Enfermedades de los Caballos/inmunología , Enfermedades de los Caballos/virología , Caballos , Humanos , Océano Índico/epidemiología , Pruebas de Neutralización , Estudios Seroepidemiológicos , Fiebre del Nilo Occidental/epidemiología , Fiebre del Nilo Occidental/transmisión , Fiebre del Nilo Occidental/virología , Virus del Nilo Occidental/inmunología
5.
Epidemiol Infect ; 141(4): 745-50, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22814442

RESUMEN

It is difficult to assess the mortality burden of influenza epidemics in tropical countries. Until recently, the burden of influenza was believed to be negligible in Africa. We assessed the impact of the 2009 influenza epidemic on mortality in Madagascar by conducting Poisson regression analysis on mortality data from the deaths registry, after the first wave of the 2009 A(H1N1) virus pandemic. There were 20% more human deaths than expected in Antananarivo, Madagascar in November 2009, with excess mortality in the ⩾50 years age group (relative risk 1·41). Furthermore, the number of deaths from pulmonary disease was significantly higher than the number of deaths from other causes during this pandemic period. These results suggest that the A(H1N1) 2009 virus pandemic may have been accompanied by an increase in mortality.


Asunto(s)
Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/mortalidad , Enfermedades Pulmonares/mortalidad , Pandemias , Adolescente , Adulto , Factores de Edad , Anciano , Niño , Humanos , Madagascar/epidemiología , Persona de Mediana Edad , Análisis de Regresión , Riesgo
6.
Mucosal Immunol ; 1(4): 279-88, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19079189

RESUMEN

Loss of CD4(+) T cells in the gut is necessary but not sufficient to cause AIDS in animal models, raising the possibility that a differential loss of CD4(+) T-cell subtypes may be important. We found that CD4(+) T cells that produce interleukin (IL)-17, a recently identified lineage of effector CD4(+) T-helper cells, are infected by SIV(mac251)in vitro and in vivo, and are found at lower frequency at mucosal and systemic sites within a few weeks from infection. In highly viremic animals, Th1 cells predominates over Th17 T cells and the frequency of Th17 cells at mucosal sites is negatively correlated with plasma virus level. Because Th17 cells play a central role in innate and adaptive immune response to extracellular bacteria, our finding may explain the chronic enteropathy in human immunodeficiency virus (HIV) infection. Thus, therapeutic approaches that reconstitute an adequate balance between Th1 and Th17 may be beneficial in the treatment of HIV infection.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Interleucina-17/inmunología , Membrana Mucosa/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Virus de la Inmunodeficiencia de los Simios/fisiología , Células TH1/inmunología , Animales , Antígenos Virales/inmunología , Humanos , Linfocitos/inmunología , Macaca mulatta , Membrana Mucosa/virología , Síndrome de Inmunodeficiencia Adquirida del Simio/virología , Virus de la Inmunodeficiencia de los Simios/inmunología , Replicación Viral/fisiología
7.
J Infect Dis ; 184(3): 278-84, 2001 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-11443552

RESUMEN

The annual incidence of Q fever in French Guiana was found to have increased in 1996 and was 37/100,000 population over the last 4 years. Subsequent investigations in Cayenne and its suburbs indicated that a wild reservoir of the bacteria was responsible for the epidemiologic pattern. A case-control study showed that residence near a forest and occupations and activities that result in exposure to aerosols of dusts from the soil are risk factors for Q fever. By means of time-series analysis, a strong positive correlation between rainfall and the incidence of Q fever with a time lag of 1-3 months was found. The spatial distribution of the cases showed that transmission occurs widely throughout greater Cayenne, which is incompatible with a pinpoint source of contamination. Transmission from livestock and dissemination of the bacteria by the wind appeared to be unlikely, which strengthens the hypothesis that a wild reservoir is responsible for transmission.


Asunto(s)
Infecciones Comunitarias Adquiridas/transmisión , Reservorios de Enfermedades , Fiebre Q/transmisión , Población Suburbana , Adolescente , Adulto , Microbiología del Aire , Animales , Animales Salvajes , Anuros , Aves , Estudios de Casos y Controles , Gatos , Niño , Preescolar , Quirópteros , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/epidemiología , Coxiella burnetii/aislamiento & purificación , Polvo , Femenino , Guyana Francesa/epidemiología , Geografía , Cobayas , Humanos , Lactante , Masculino , Marsupiales , Exposición Profesional , Fiebre Q/diagnóstico , Fiebre Q/epidemiología , Roedores , Estaciones del Año , Microbiología del Suelo , Población Urbana
8.
Clin Infect Dis ; 30(1): 188-90, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10619752

RESUMEN

Tonate virus, subtype IIIB of the Venezuelan equine encephalitis (VEE) complex, was first isolated in 1973 in French Guiana, South America. However, very little is known about its pathogenicity; it was considered to be responsible for only mild dengue-like syndromes. In 1998, a 2-month-old boy living along the Oyapock river in French Guiana was hospitalized for fever and generalized status myoclonus, and despite treatment the patient died 72 h after admission. Testing showed the presence of IgM specific for viruses of the VEE complex. A sensitive seminested polymerase chain reaction derived from a previous study was developed to detect viruses from the VEE complex, since no virus could be recovered from clinical specimens cultured on mosquito cells or from intracerebral inoculation into newborn mice. The genome of a virus from the VEE complex was detected in postmortem brain biopsies, and Tonate virus was identified by direct sequencing. This is the first reported case of human encephalitis due to Tonate virus.


Asunto(s)
Virus de la Encefalitis Equina Venezolana/clasificación , Virus de la Encefalitis Equina Venezolana/aislamiento & purificación , Encefalomielitis Equina Venezolana/diagnóstico , Animales , Anticuerpos Antivirales/sangre , Encéfalo/virología , Virus de la Encefalitis Equina Venezolana/genética , Virus de la Encefalitis Equina Venezolana/inmunología , Encefalomielitis Equina Venezolana/virología , Humanos , Lactante , Masculino , Ratones , Datos de Secuencia Molecular , ARN Viral/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN
9.
Emerg Infect Dis ; 5(3): 429-32, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10341180

RESUMEN

The first case of yellow fever in French Guiana since 1902 was reported in March 1998. The yellow fever virus genome was detected in postmortem liver biopsies by seminested polymerase chain reaction. Sequence analysis showed that this strain was most closely related to strains from Brazil and Ecuador.


Asunto(s)
Fiebre Amarilla/epidemiología , Virus de la Fiebre Amarilla/genética , ADN Viral/análisis , Resultado Fatal , Femenino , Guyana Francesa/epidemiología , Humanos , Hígado/virología , Filogenia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN , Fiebre Amarilla/virología , Virus de la Fiebre Amarilla/aislamiento & purificación
10.
Epidemiol Infect ; 123(3): 511-3, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10694165

RESUMEN

A laboratory worker developed clinical signs of infection with Mayaro virus (Togaviridae), an arbovirus of South and Central America, 6 days after preparation of Mayaro viral antigen and 10 days after a trip to a rain forest. There was no evidence of skin lesions during the antigen preparation, and level 3 containment safety measures were followed. Therefore, molecular characterization of the virus was undertaken to identify the source of infection. RT-PCR and DNA sequence comparisons proved the infection was with the laboratory strain. Airborne Mayaro virus contamination is thus a hazard to laboratory personnel.


Asunto(s)
Personal de Laboratorio Clínico , Exposición Profesional , Infecciones por Togaviridae/transmisión , Togaviridae/genética , Secuencia de Bases , ADN Viral/análisis , Humanos , Exposición por Inhalación , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Togaviridae/patogenicidad , Infecciones por Togaviridae/genética
11.
J Biol Chem ; 273(28): 17817-23, 1998 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-9651384

RESUMEN

We have shown previously that ADP released upon platelet adhesion mediated by alphaIIb beta3 integrin triggers accumulation of phosphatidylinositol 3',4'-bisphosphate (PtdIns-3,4-P2) (Gironcel, D. , Racaud-Sultan, C., Payrastre, B., Haricot, M., Borchert, G., Kieffer, N., Breton, M., and Chap, H. (1996) FEBS Lett. 389, 253-256). ADP has also been involved in platelet spreading. Therefore, in order to study a possible role of phosphoinositide 3-kinase in platelet morphological changes following adhesion, human platelets were pretreated with specific phosphoinositide 3-kinase inhibitors LY294002 and wortmannin. Under conditions where PtdIns-3, 4-P2 synthesis was totally inhibited (25 microM LY294002 or 100 nM wortmannin), platelets adhered to the fibrinogen matrix, extended pseudopodia, but did not spread. Moreover, addition of ADP to the medium did not reverse the inhibitory effects of phosphoinositide 3-kinase inhibitors on platelet spreading. Although synthetic dipalmitoyl PtdIns-3,4-P2 and dipalmitoyl phosphatidylinositol 3',4', 5'-trisphosphate restored only partially platelet spreading, phosphatidylinositol 4',5'-bisphosphate (PtdIns-4,5-P2) was able to trigger full spreading of wortmannin-treated adherent platelets. Following 32P labeling of intact platelets, the recovery of [32P]PtdIns-4,5-P2 in anti-talin immunoprecipitates from adherent platelets was found to be decreased upon treatment by wortmannin. These results suggest that the lipid products of phosphoinositide 3-kinase are required but not sufficient for ADP-induced spreading of adherent platelets and that PtdIns-4,5-P2 could be a downstream messenger of this signaling pathway.


Asunto(s)
Adenosina Difosfato/farmacología , Plaquetas/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Fosfatidilinositol 4,5-Difosfato/metabolismo , Fosfatidilinositoles/metabolismo , Transducción de Señal , Androstadienos/farmacología , Plaquetas/citología , Plaquetas/metabolismo , Adhesión Celular/efectos de los fármacos , Cromonas/farmacología , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Humanos , Indoles/farmacología , Maleimidas/farmacología , Morfolinas/farmacología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Talina/metabolismo , Wortmanina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA